Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:42 pm Purchase | 2025-12-31 | 13G | VSEE HEALTH, INC. VSEE | ARMISTICE CAPITAL LLC | 1,889,308 9.990% | 1,889,308 (New Position) | Filing History |
| 2026-02-17 9:42 pm Purchase | 2025-12-31 | 13G | VIRAX BIOLABS GROUP LTD SHS NE VRAX | ARMISTICE CAPITAL LLC | 823,909 9.990% | 595,867 (+261.30%) | Filing History |
| 2026-02-17 9:41 pm Purchase | 2025-12-31 | 13G | SOBR SAFE INC PAR $0.00001 SOBR | ARMISTICE CAPITAL LLC | 168,285 9.990% | 168,285 (New Position) | Filing History |
| 2026-02-17 9:41 pm Purchase | 2025-12-31 | 13G | REKOR SYS INC REKR | ARMISTICE CAPITAL LLC | 14,061,005 9.990% | 11,568,166 (+464.06%) | Filing History |
| 2026-02-17 9:41 pm Sale | 2025-12-31 | 13G | ENERGOUS CORP COM PAR $0.00001 WATT | ARMISTICE CAPITAL LLC | 114,239 4.990% | -71,022 (-38.34%) | Filing History |
| 2026-02-17 9:39 pm Sale | 2025-12-31 | 13G | VERRICA PHARMACEUTICALS INC CO VRCA | ARMISTICE CAPITAL LLC | 439,657 4.990% | -199,536 (-31.22%) | Filing History |
| 2026-02-17 9:38 pm Sale | 2025-12-31 | 13G | VOLITIONRX LIMITED VNRX | ARMISTICE CAPITAL LLC | 6,449,635 4.990% | -2,930,790 (-31.24%) | Filing History |
| 2026-02-17 9:38 pm Sale | 2025-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | ARMISTICE CAPITAL LLC | 3,763,891 4.210% | -2,960,109 (-44.02%) | Filing History |
| 2026-02-17 9:37 pm Sale | 2025-12-31 | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | ARMISTICE CAPITAL LLC | 2,764,000 4.820% | -72,000 (-2.54%) | Filing History |
| 2026-02-17 9:37 pm Sale | 2025-12-31 | 13G | SOLIGENIX INC PAR $.001 NE SNGX | ARMISTICE CAPITAL LLC | 529,731 4.990% | -178,269 (-25.18%) | Filing History |
| 2026-02-17 9:37 pm Purchase | 2025-12-31 | 13G | REVELATION BIOSCIENCES INC REVB | ARMISTICE CAPITAL LLC | 288,332 4.990% | 225,643 (+359.94%) | Filing History |
| 2026-02-17 9:36 pm Purchase | 2025-12-31 | 13G | PROMIS NEUROSCIENCES INC PMN | ARMISTICE CAPITAL LLC | 504,673 0.930% | 385,692 (+324.16%) | Filing History |
| 2026-02-17 9:36 pm Purchase | 2025-12-31 | 13G | TREACE MED CONCEPTS INC TMCI | ARMISTICE CAPITAL LLC | 6,364,000 9.990% | 48,000 (+0.76%) | Filing History |
| 2026-02-17 9:34 pm Sale | 2025-12-31 | 13G | PRESIDIO PPTY TR INC SQFT | ARMISTICE CAPITAL LLC | 159,722 9.990% | -1,330 (-0.83%) | Filing History |
| 2026-02-17 9:33 pm Sale | 2025-12-31 | 13G | STRYVE FOODS INC SNAX | ARMISTICE CAPITAL LLC | 397,085 9.990% | -42,274 (-9.62%) | Filing History |
| 2026-02-17 9:33 pm Sale | 2025-12-31 | 13G | ARIDIS PHARMACEUTICALS INC ARDS | ARMISTICE CAPITAL LLC | 1,512,444 9.450% | -3,583,807 (-70.32%) | Filing History |
| 2025-11-14 6:46 pm Sale | 2025-09-30 | 13G | DATA STORAGE CORPORATION COM N DTST | ARMISTICE CAPITAL LLC | 375,440 7.270% | -150,143 (-28.57%) | Filing History |
| 2025-11-14 6:45 pm Purchase | 2025-09-30 | 13G | KURA ONCOLOGY INC KURA | ARMISTICE CAPITAL LLC | 4,672,000 5.370% | 1,394,728 (+42.56%) | Filing History |
| 2025-11-14 6:44 pm Sale | 2025-09-30 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | ARMISTICE CAPITAL LLC | 189,562 4.990% | -39,022 (-17.07%) | Filing History |
| 2025-11-14 6:44 pm Purchase | 2025-09-30 | 13G | GENELUX CORP COM GNLX | ARMISTICE CAPITAL LLC | 4,223,277 9.990% | 4,223,277 (New Position) | Filing History |